✨ Free AI Report
Renalytix Plc: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Renalytix Plc
Research Preview

Renalytix Plc: Business Overview, Financials & Competitive Analysis

Renalytix is an AI-enabled in vitro diagnostics company focused on kidney disease management. The company's flagship product, KidneyIntelX, uses artificial intelligence, blood-based biomarkers, genetics, and patient h...

Analyst-debate audio for Renalytix Plc

AskCyborg analysts argue the bull and bear cases for Renalytix Plc across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Renalytix Plc OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
4/ 10Mixed

Cyborg Score thesis

High-potential AI diagnostics platform with strong regulatory positioning, but challenged by slow commercial adoption and capital...

Read the full analyst-debate transcript →
Industry AI-Enabled In Vitro Diagnostics and Laboratory Services
2 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest Renalytix Plc Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Renalytix Plc Overview

Pro stress-test →

Renalytix is an AI-enabled in vitro diagnostics company focused on kidney disease management. The company's flagship product, KidneyIntelX, uses artificial intelligence, blood-based biomarkers, genetics, and patient health data to predict rapid kidney function decline in patients with type 2 diabetes and chronic kidney disease.

Strategic Profile

Pro stress-test →

Renalytix is the global founder and leader in bioprognosis for kidney health, holding FDA authorization for its KidneyIntelX test with broad insurance coverage. The company leverages strategic partnerships with major pharmaceutical companies like AstraZeneca and healthcare systems to expand adoption and clinical validation of its prognostic platform.

Competitive Landscape

Pro stress-test →

Renalytix operates in the AI-enabled diagnostics space competing against traditional diagnostic providers and emerging AI health tech companies. The company's niche focus on kidney disease prognosis provides differentiation, though it faces broader competition from large diagnostic lab services (LabCorp, Quest Diagnostics) and specialized kidney health platforms. Market adoption depends on physician education and demonstrated clinical outcomes value.

Industry Context

Renalytix Plc operates in AI-Enabled In Vitro Diagnostics and Laboratory Services.

Key facts

Founded: 2018 · Headquarters: London, UK · Employees: 46 · Revenue: Unknown · Market cap: Unknown

What the analysts stress-tested

The top findings that survived the multi-agent debate for Renalytix Plc.

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Renalytix Plc has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Kidney Disease DiagnosticsTraditional lab diagnostics with broad menu including kidney function testsAI Health AnalyticsBroad-based AI diagnostic platforms competing in precision health space

Compare Renalytix Plc with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Renalytix Plc operates in AI-Enabled In Vitro Diagnostics and Laboratory Services. See how the rest of the sector scores on the Cyborg framework.

Browse AI-Enabled In Vitro Diagnostics and Laboratory Services research →
NEW · MCP server

Ask your AI assistant about Renalytix Plc

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Renalytix Plc and its top competitor on Cyborg Score”
“What did Renalytix Plc do this quarter?”
“Is Renalytix Plc a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Renalytix Plc do?+
Renalytix is an AI-enabled in vitro diagnostics company focused on kidney disease management. The company's flagship product, KidneyIntelX, uses artificial intelligence, blood-based biomarkers, genetics, and patient h...
What is Renalytix Plc's Cyborg Score?+
Renalytix Plc has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Renalytix Plc's main competitors?+
Named competitors include Kidney Disease Diagnostics, AI Health Analytics. The full competitive landscape is in the AskCyborg report.
How can I get the full Renalytix Plc research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Renalytix Plc research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Renalytix Plc over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual